Evaluation of the long-term safety and tolerability of cariprazine in patients with schizophrenia: results from a 1-year open-label study

Andrew J.Cutler; SureshDurgam; YaoWang; RaffaeleMigliore; KaifengLu; IstvánLaszlovszky; Gy?rgyNémeth

首页> 外文期刊>CNS spectrums >Evaluation of the long-term safety and tolerability of cariprazine in patients with schizophrenia: results from a 1-year open-label study

【24h】

Evaluation of the long-term safety and tolerability of cariprazine in patients with schizophrenia: results from a 1-year open-label study

机译：精神分裂症患者甘唑嗪的长期安全性和耐受性评价：1年开放标签研究的结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《CNS spectrums》 |2018年第1期|共12页
作者
Andrew J.Cutler; SureshDurgam; YaoWang; RaffaeleMigliore; KaifengLu; IstvánLaszlovszky; Gy?rgyNémeth;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学与精神病学;
关键词
Cariprazine; schizophrenia; long-term safety; antipsychotics; dopamine receptors;

机译：甘披嗪;精神分裂症;长期安全;抗精神病药;多巴胺受体;

相似文献

外文文献
中文文献
专利

1. Evaluation of the long-term safety and tolerability of cariprazine in patients with schizophrenia: results from a 1-year open-label study [J] . Andrew J.Cutler, SureshDurgam, YaoWang, CNS spectrums . 2018,第1期

机译：精神分裂症患者甘唑嗪的长期安全性和耐受性评价：1年开放标签研究的结果
2. A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Maintenance Treatment in Adults with Schizophrenia [J] . Forbes Andy, Hobart Mary, Ouyang John, The international journal of neuropsychopharmacology . 2018,第5期

机译：一项长期，开放标签的研究，评估布雷普拉唑作为成人精神分裂症维持治疗的安全性和耐受性
3. The safety and tolerability of cariprazine in patients with manic or mixed episodes associated with bipolar I disorder: A 16-week open-label study [J] . Terence A. Ketter, Gary S. Sachs, Suresh Durgam, Journal of affective disorders . 2017,第期

机译：与双极I紊乱相关的躁狂或混合发作患者的甲尿嘧啶的安全性和耐受性：16周的开放标签研究
4. Pharmacokinetics and Tolerability of Sublingual Fentanyl in Healthy Japanese and Caucasian Volunteers: Phase I, Open-Label Single-Dose Study [C] . U. Lorch, F. Farrell, J. Kilborn, International Pain Clinic Congress . 2008

机译：健康日本和白种人志愿者舌下芬太尼的药代动力学和耐受性：I期，开放标签单剂量研究
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Safety and tolerability of cariprazine in the long-term treatment of schizophrenia: results from a 48-week single-arm open-label extension study [O] . Suresh Durgam, William M. Greenberg, Dayong Li, -1

机译：Cariprazine在长期精神分裂症治疗中的安全性和耐受性：一项为期48周的单臂开放标签扩展研究的结果
7. Safety and tolerability of cariprazine in the long-term treatment of schizophrenia: results from a 48-week, single-arm, open-label extension study [O] . Suresh Durgam, William M. Greenberg, Dayong Li, 2016

机译：Cariprazine在长期精神分裂症治疗中的安全性和耐受性：一项为期48周的单臂开放标签扩展研究的结果

Evaluation of the long-term safety and tolerability of cariprazine in patients with schizophrenia: results from a 1-year open-label study

著录项

相似文献

相关主题

期刊订阅